An2 Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in An2 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including An2 Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in An2 Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $189k | 178k | 1.06 |
| 2024-12-31 | $414 | 300 | 1.38 |
| 2024-09-30 | $303 | 303 | 1.00 |
| 2024-06-30 | $35k | 18k | 2.00 |
| 2024-03-31 | $14k | 4.2k | 3.33 |
| 2023-12-31 | $68k | 3.3k | 20.50 |
| 2023-09-30 | $45k | 2.8k | 16.08 |
| 2023-06-30 | $359k | 42k | 8.50 |
| 2022-12-31 | $394k | 41k | 9.53 |
| 2022-06-30 | $287k | 40k | 7.11 |
| 2022-03-31 | $13k | 885 | 14.60 |